Depending on the stage of breast cancer, the general 5-year survival rates for women are: Stage 0 or 1: nearly 100 percent. Stage 2: about 93 percent. Stage 3: around 72 percent.
ILC is treated with a lumpectomy or mastectomy, depending on the size and location of the tumor. In addition, your medical oncologist and radiation oncologist may recommend chemotherapy and/or radiation. Hormonal therapy is nearly always part of the treatment for lobular cancers.
About 10% of all invasive breast cancers are invasive lobular carcinomas. (About 80% are invasive ductal carcinomas.) Invasive means that the cancer has “invaded” or spread to the surrounding breast tissues. Over time, invasive lobular carcinoma can spread to the lymph nodes and possibly to other areas of the body.
It's not clear what causes invasive lobular carcinoma. Doctors know that invasive lobular carcinoma begins when cells in one or more milk-producing glands of the breast develop mutations in their DNA. The mutations lead to the inability to control cell growth, which results in the cells dividing and growing rapidly.
Symptoms of Invasive Lobular Carcinoma
Thickening or hardening in the breast (as opposed to a distinct lump) An area of swelling or fullness. A change to the texture of skin on your breast or nipple, like dimples or an irritated, red or scaly area. Your nipple turns inward.Invasive Lobular Carcinoma (ILC) Invasive Lobular Carcinoma (ILC), also known as infiltrating lobular carcinoma, is the second most common form of breast cancer diagnosed in the United States, representing 10-15 percent of diagnosed invasive breast cancers.
Stage 0 means the cancer cells are still within the breast lobule and have not invaded deeper into the surrounding fatty breast tissue. This is called lobular carcinoma in situ (LCIS), a non-invasive breast cancer. In stage 0 cancer, the cancer has not spread to lymph nodes or distant sites.
Inherited genetic cancer syndromes.
Women with a rare inherited condition called hereditary diffuse gastric cancer syndrome have an increased risk of both stomach (gastric) cancer and invasive lobular carcinoma. Women with certain inherited genes may have an increased risk of breast and ovarian cancers.Survival rate
If cancer has advanced, for example by spreading beyond the breast tissue, survival rates are likely to be lower. Depending on the stage of breast cancer, the general 5-year survival rates for women are: Stage 0 or 1: nearly 100 percent. Stage 2: about 93 percent.Well-differentiated carcinomas have relatively normal-looking cells that do not appear to be growing rapidly and are arranged in small tubules for ductal cancer and cords for lobular cancer. These cancers tend to grow and spread slowly and have a better prognosis (outlook).
Instead of clustering together, lobular cells spread out single file like tree branches or spider webs or mesh, which explains why surgeons and oncologists often refer to it as “sneaky” or “insidious.” Because the cells don't stick together well, there's often no lump, making it harder for women to find during self-
An entire course of chemotherapy usually takes about 3 to 6 months. Some examples of the many chemotherapy medicines that may be used to treat invasive lobular carcinoma are: Adriamycin (chemical name: doxorubicin)
Breast cancer has to divide 30 times before it can be felt. Up to the 28th cell division, neither you nor your doctor can detect it by hand. With most breast cancers, each division takes one to two months, so by the time you can feel a cancerous lump, the cancer has been in your body for two to five years.
There may not be any obvious signs of lobular breast cancer at first. Unlike more common breast cancers, lobular breast cancer is less likely to form into a lump in the breast tissue or under the arm. Instead, you may feel a fullness, thickening or swelling in one area that feels different from the surrounding area.
Alcohol Linked with Lobular Breast Cancer. Although alcohol is a well-established risk factor for breast cancer, it may be more strongly linked with lobular breast cancer than with ductal breast cancer. These results were published in the Journal of the National Cancer Institute.
Lobular carcinoma in situ (LCIS) is an uncommon condition in which abnormal cells form in the milk glands (lobules) in the breast. LCIS isn't cancer. But being diagnosed with LCIS indicates that you have an increased risk of developing breast cancer.
This is called an invasive ductal cancer. But less commonly it can start in the breast lobes and called an invasive lobular breast cancer. As you know your pathology report has shown a mixture of both types and this is often called an invasive mammary cancer.
Over time, invasive lobular carcinoma can spread to the lymph nodes and possibly to other areas of the body. Although invasive lobular carcinoma can affect women at any age, it is more common as women grow older.
Treatment. These treatments can include surgery, such as a lumpectomy or mastectomy, or radiation therapy that directly attacks the cancer. Systemic treatments for ILC attack cancer cells that have spread beyond the breast tissue. Chemotherapy and hormonal therapy are the two main systemic treatments for ILC.
There are two main types of breast cancer: „„Ductal carcinoma starts in the tubes (ducts) that move milk from the breast to the nipple. Most breast cancers are of this type. „„Lobular carcinoma starts in the parts of the breast, called lobules, which produce milk.
The most aggressive breast cancers include: Triple-negative breast cancer: This type of breast cancer tests negative for the hormones estrogen and progesterone, and the protein HER2. Inflammatory breast cancer: This rare form of cancer is named because it causes breast swelling and redness.
If you have been diagnosed with lobular breast cancer (ILC), it's important to know where lobular breast cancer can metastasize and the symptoms. ILC can metastasize (spread) to common sites such as the bones, lungs, brain and liver. ILC can metastasize many years after diagnosis.
